AUSTIN, Texas, June 2, 2021 /PRNewswire/ -- Fagron North America, a global leader in pharmaceutical compounding, debuts the most advanced genetic test supporting medical practitioners' assessment and ...
Organic turnover growth of 7.1% CER [1], mainly driven by strong growth in North and South America Brands realized organic turnover growth of 14.8% CER Further growth of turnover and profitability ...
Nazareth (Belgium)/Rotterdam (The Netherlands), 12 April 2019 - 7am CET Fagron achieved turnover growth of 13.1% Key points Turnover increased by 13.1% to € 123.4 million Organic turnover growth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback